FDA declares 40 generics free of carcinogens as 'sartan' recalls continue
admin 5th April 2019 Uncategorised 0Amid the recalls plaguing the “sartan” drug class, the FDA released a list of 40 generics that do not contain three potentially carcinogenic compounds flagged in linked to various “sartan” drugs, including valsartan and losartan.
More: FDA declares 40 generics free of carcinogens as 'sartan' recalls continue
Source: fierce